OverviewChartNewsTraderScreen

BVT Bonus Zert AMD 31.12.2024/  DE000VD20KP0  /

Frankfurt Zert./VONT
6/18/2024  7:55:20 PM Chg.-4.500 Bid9:44:41 AM Ask9:44:41 AM Underlying Strike price Expiration date Option type
160.900EUR -2.72% 158.270
Bid Size: 1,900		 159.070
Ask Size: 1,900		 Advanced Micro Devic... - USD 12/31/2024 Call
GlobeNewswire 2:57 AM Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
GlobeNewswire 6/18 4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population E...
GlobeNewswire 6/18 EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
GlobeNewswire 6/17 D&H’s June 18 Hershey THREAD Technology Conference to Deliver AI-Readiness & Training
TeleTrader 6/17 Nasdaq opens higher with Nvidia at new record high
GlobeNewswire 6/14 Sharecare wins 22 Digital Health Awards in Spring 2024 competition
GlobeNewswire 6/14 GRANITESHARES HITS $6 BILLION AUM AS NVDL SURGES
GlobeNewswire 6/14 Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$1...
GlobeNewswire 6/13 Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Stu...
GlobeNewswire 6/13 Global High-Performance Computing Servers Market Size Projected to Reach $26 Billion By 2032
GlobeNewswire 6/12 Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at t...
GlobeNewswire 6/12 Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japa...
GlobeNewswire 6/12 Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately...
GlobeNewswire 6/11 Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
GlobeNewswire 6/11 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...
GlobeNewswire 6/11 YieldMax™ Launches Option Income Strategy ETF on Snowflake (SNOW)
GlobeNewswire 6/10 AMD to Present at the UBS Women in Tech Summit
GlobeNewswire 6/10 SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in...
GlobeNewswire 6/8 4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire 6/6 AMD to Present at the Nasdaq London Investor Conference
GlobeNewswire 6/5 Ocular Therapeutix® to Host Investor Day on June 13, 2024
GlobeNewswire 6/5 YieldMax™ ETFs Announces Monthly Distributions on MSTY (106.33%), NVDY (101.82%), CONY (84.85%), YBI...
GlobeNewswire 6/5 Micron Samples Next-Gen Graphics Memory for Gaming and AI
GlobeNewswire 6/4 Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 6/3 Coherent Appoints Jim Anderson as Chief Executive Officer